ASML’s Hidden Monopoly Is Quietly Compounding While Wall Street Debates AI Hype

Every great technological revolution produces a handful of companies with choke-point advantages so durable that their pricing power borders on the supernatural. In the AI era, the most overlooked of these may be ASML Holding — the Dutch semiconductor equipment maker that produces the only machines on Earth capable of etching the most advanced chips. On Wednesday, the company raised its full-year guidance for the second time in 2026, reporting Q2 net sales of 9.3 billion euros against analyst expectations of 8.8 billion — a 6% beat — while net profit came in at 2.9 billion euros versus 2.6 billion expected. The stock gained over 7% in early trading. More importantly, full-year revenue guidance was lifted to between 43 billion and 45 billion euros (roughly $49 billion), up sharply from the prior 36–40 billion euro forecast. That’s not a rounding error; that’s a structural rerate driven by a customer base in a genuine arms race.

ASML’s extreme ultraviolet (EUV) lithography machines — which can cost upward of $380 million apiece — are essential to producing the most advanced AI chips at scale. No other company in the world can manufacture them. CEO Christophe Fouquet said orders were “extremely strong” in the first half of the year as chipmakers like TSMC raced to expand production capacity. South Korea accounted for 43% of ASML’s Q2 sales, with Taiwan a close second and China — now navigating looming U.S. export restrictions — contributing just 14% of Q2 revenue. The company maintained its expectation that China will represent around 20% of full-year sales, suggesting the export control headwind is manageable and largely priced in. Meanwhile, UBS analysts noted in a July 10 note that AI-driven demand for leading-edge chip production capacity is set to accelerate further in the second half of the year, lending structural support well beyond any single earnings quarter.

For long-term investors, the ASML story rests on one of the most defensible competitive positions in the history of industrial capitalism: a monopoly not enforced by patents alone but by 30 years of accumulated engineering knowledge embedded in thousands of proprietary components, supplier relationships, and precision tolerances that simply cannot be replicated quickly. Morningstar’s senior equity analyst Javier Correonero acknowledged the company is “doing a great job” executing, though he cautions that the stock, trading at roughly 50x forward earnings — near its Covid-era peak multiple — has a lot of optimism already baked in. His target implies a more conservative 35–40x forward PE. That is a fair caution. But the underlying reality is that so long as the world demands more silicon at finer and finer geometries, ASML collects the toll. The question for patient investors is not whether the moat is real — it self-evidently is — but whether to wait for a multiple compression or to accept that scarcity, over long holding periods, tends to compound in shareholders’ favor. History suggests that buying genuine monopolies at reasonable prices and holding through periods of apparent overvaluation has been one of the most reliable wealth-building strategies available. ASML’s guidance raise, the second in a single year, is not a fluke. It is the sound of a moat deepening.